Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis

References

• Alam MF, Laskar AA, Choudhary HH, Younus H. 2016. Human salivary aldehyde dehydrogenase: purification, kinetic characterization and effect of ethanol, hydrogen peroxide and sodium dodecyl sulfate on the activity of the enzyme. Cell Biochem Biophys. 74:307–315.
   PubMed Web of Science ®Google Scholar
• Alam MF, Laskar AA, Maryam L, Younus H. 2016. Activation of human salivary aldehyde dehydrogenase by sulforaphane: mechanism and significance. PLoS One. 11:e0168463.
   PubMed Web of Science ®Google Scholar
• Ambroziak W, Pietruszko R. 1993. Metabolic role of aldehyde dehydrogenase. Adv Exp Med Biol. 328:5–15.
   PubMedGoogle Scholar
• Anzenbacher P, Anzenbacherová E. 2012. Drug-metabolizing enzymes- an overview. In: Anzenbacher P, Zanger UM, editors. Metabolism of drugs and other xenobiotics. Weinheim (Germany): Wiley-VCH Verlag GmbH & Co. KGaA; p. 3–26.
   Google Scholar
• Atkinson R. 1988. Atmospheric transformations of automotive emissions. In: Watson AY, Bates RR, Kennedy D, editors. Air pollution, the automobile, and public health. Washington (DC): National Academies Press; p. 99–132.
   Google Scholar
• Banfi P, Lanzi C, Falvella FS, Gariboldi M, Gambetta RA, Dragani TA. 1994. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is downregulated in mouse liver tumors and in tumor cell lines. Mol Pharmacol. 46:896–900.
   PubMed Web of Science ®Google Scholar
• Banh A, Xiao N, Cao H, Chen CH, Kuo P, Krakow T, Bavan B, Khong B, Yao M, Ha C. 2011. A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. Clin Cancer Res. 17:7265–7272.
   PubMed Web of Science ®Google Scholar
• Barrera G, Pizzimenti S, Daga M, Dianzani C, Cetrangolo GP, Lepore A, Arcaro A, Gentile F. 2017. Aldehydes derived from lipid peroxidation in cancer and autoimmunity. In: Catalá A, editor. Lipid peroxidation: inhibition, effects and mechanisms. New York: Nova Science Publishers Inc.; p. 147–171.
   Google Scholar
• Barski OA, Tipparaju SM, Bhatnagar A. 2008. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev. 40:553–624.
   PubMed Web of Science ®Google Scholar
• Beauchamp RO, Andjelkovich DA, Kligerman AD, Morgan KT, Heck HD. 1985. A critical review of the literature on acrolein toxicity. Crit Rev Toxicol.14:309–380.
   PubMed Web of Science ®Google Scholar
• Belmont-Díaz JA, Calleja-Castañeda LF, Yoval-Sánchez B, Rodríguez-Zavala JS. 2015. Tamoxifen, an anticancer drug, is an activator of human aldehyde dehydrogenase 1A1. Proteins. 83:105–116.
   PubMed Web of Science ®Google Scholar
• Belyaeva OV, Korkina OV, Stetsenko AV, Kedishvili NY. 2008. Human retinol dehydrogenase 13 (RDH13) is a mitochondrial short-chain dehydrogenase/reductase with a retinaldehyde reductase activity. FEBS J. 275:138–147.
   PubMed Web of Science ®Google Scholar
• Bhatnagar A. 2006. Environmental cardiology: pollution and heart disease. Circ Res. 99:187–197.
   Web of Science ®Google Scholar
• Black W, Chen Y, Matsumoto A, Thompson DC, Lassen N, Pappa A, Vasiliou V. 2012. Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal. Free Radic Biol Med. 52:1937–1944.
   PubMed Web of Science ®Google Scholar
• Black W, Vasiliou V. 2009. The aldehyde dehydrogenase gene superfamily resource center. Hum Genomics. 4:136–142.
   PubMedGoogle Scholar
• Blackwell LF, Bennett AF, Buckley PD. 1983. Relationship between the mechanisms of the esterase and dehydrogenase activities of the cytoplasmic aldehyde dehydrogenase from sheep liver. An alternative view. Biochemistry. 22:3784–3791.
   PubMed Web of Science ®Google Scholar
• Boddy AV, Yule SM. 2000. Metabolism and pharmacokinetics of oxazaphosphorines. Clin Pharmacokinet. 38:291–304.
   PubMed Web of Science ®Google Scholar
• Bogen A, Buske C, Hiddemann W, Bohlander SK, Christ O. 2017. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells. Exp Hematol. 47:54–63.
   PubMed Web of Science ®Google Scholar
• Bogucka M, Giebułtowicz J, Zawada K, Wroczyński P, Wierzchowski J, Pietrzak M, Piekarczyk P, Romanowska K. 2009. The oxidation status of ALDH3A1 in human saliva and its correlation with antioxidant capacity measured by ORAC method. Acta Pol Pharm. 66:477–482.
   PubMed Web of Science ®Google Scholar
• Bohren KM, Bullock B, Wermuth B, Gabbay KH. 1989. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem. 264:9547–9551.
   PubMed Web of Science ®Google Scholar
• Bray JE, Marsden BD, Oppermann U. 2009. The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary. Chem Biol Interact. 178:99–109.
   PubMed Web of Science ®Google Scholar
• Brocker C, Lassen N, Estey T, Pappa A, Cantore M, Orlova VV, Chavakis T, Kavanagh KL, Oppermann U, Vasiliou V. 2010. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J Biol Chem. 285:18452–18463.
   PubMed Web of Science ®Google Scholar
• Brocker C, Vasiliou M, Carpenter S, Carpenter C, Zhang Y, Wang X, Kotchoni SO, Wood AJ, Kirch H-H, Kopečný D, et al. 2013. Aldehyde dehydrogenase (ALDH) superfamily in plants: gene nomenclature and comparative genomics. Planta. 237:189–210.
   PubMed Web of Science ®Google Scholar
• Buckley LA, Jiang XZ, James RA, Morgan KT, Barrow CS. 1984. Respiratory tract lesions induced by sensory irritants at the RD50 concentration. Toxicol Appl Pharmacol. 74:417–429.
   PubMed Web of Science ®Google Scholar
• Bunting KD, Townsend AJ. 1996. Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme. J Biol Chem. 271:11891–11896.
   PubMed Web of Science ®Google Scholar
• Calderaro J, Nault JC, Bioulac-Sage P, Laurent A, Blanc JF, Decaens T, Zucman-Rossi J. 2014. ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ss-catenin pathway. Virchows Arch. 464:53–60.
   PubMed Web of Science ®Google Scholar
• Canuto RA, Ferro M, Muzio G, Bassi AM, Leonarduzzi G, Maggiora M, Adamo D, Poli G, Lindahl R. 1994. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis. 15:1359–1364.
   PubMed Web of Science ®Google Scholar
• Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. 2008. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science. 321:1493–1495.
   PubMed Web of Science ®Google Scholar
• Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D. 2014. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev. 94:1–34.
   PubMed Web of Science ®Google Scholar
• Chen CH, Sun L, Mochly-Rosen D. 2010. Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res. 88:51–57.
   PubMed Web of Science ®Google Scholar
• Chern MK, Pietruszko R. 1995. Human aldehyde dehydrogenase E3 isozyme is a betaine aldehyde dehydrogenase. Biochem Biophys Res Commun. 213:561–568.
   PubMed Web of Science ®Google Scholar
• Coelho C, Foti A, Hartmann T, Santos-Silva T, Leimkühler S, Romão MJ. 2015. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase. Nat Chem Biol. 11:779–783.
   PubMed Web of Science ®Google Scholar
• Cotton RW, Goldman D. 1988. Review of the molecular biology of the human alcohol dehydrogenase genes and gene products. Adv Alcohol Subst Abuse. 7:171–182.
   PubMedGoogle Scholar
• Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL. 2009. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med. 13:2236–2252.
   PubMed Web of Science ®Google Scholar
• Croker AK, Rodriguez-Torres M, Xia Y, Pardhan S, Leong HS, Lewis JD, Allan AL. 2017. Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells. Int J Mol Sci.18:2039.
   PubMed Web of Science ®Google Scholar
• Croom E. 2012. Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci. 112:31–88.
   PubMed Web of Science ®Google Scholar
• Daiber A, Munzel T. 2010. Nitrate reductase activity of mitochondrial aldehyde dehydrogenase (ALDH-2) as a redox sensor for cardiovascular oxidative stress. Methods Mol Biol. 594:43–55.
   PubMedGoogle Scholar
• Deetz JS, Luehr CA, Vallee BL. 1984. Human liver alcohol dehydrogenase isozymes: reduction of aldehydes and ketones. Biochemistry. 23:6822–6828.
   PubMed Web of Science ®Google Scholar
• Di L. 2014. The role of drug metabolizing enzymes in clearance. Expert Opin Drug Metab Toxicol. 10:379–393.
   PubMed Web of Science ®Google Scholar
• Dollé L, Gao B. 2015. Pharmacological chaperone therapies: can aldehyde dehydrogenase activator make us healthier? J Hepatol. 62:1228–1230.
   PubMed Web of Science ®Google Scholar
• Dong YJ, Peng TK, Yin SJ. 1996. Expression and activities of class IV alcohol dehydrogenase and class III aldehyde dehydrogenase in human mouth. Alcohol. 13:257–262.
   PubMed Web of Science ®Google Scholar
• Dyck LE. 1995. Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots. Alcoholism Clin Exp Res. 19:420–426.
   PubMed Web of Science ®Google Scholar
• Eaton DL, Gallagher EP. 2010. General overview of toxicology. Compr Toxicol. 1:3–45.
   Google Scholar
• Edenberg HJ, Bosron WF. 2010. Alcohol dehydrogenases. Compr Toxicol. 4:111–130.
   Google Scholar
• Ellis EM. 2007. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther. 115:13–24.
   PubMed Web of Science ®Google Scholar
• Endo S, Miyagi N, Matsunaga T, Hara A, Ikari A. 2016. Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun. 472:231–236.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:81–128.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Zollner H, Schaur RJ. 1990. Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence and determination. In: Vigo-Pelfrey C, editor. Membrane lipid oxidation. Boca Raton (FL): CRC Press; p. 239–268.
   Google Scholar
• Estey T, Piatigorsky J, Lassen N, Vasiliou V. 2007. ALDH3A1: a corneal crystallin with diverse functions. Exp Eye Res. 84:3–12.
   PubMed Web of Science ®Google Scholar
• Feron VJ, Til HP, de Vrijer F, Woutersen RA, Cassee FR, van Bladeren PJ. 1991. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat Res. 259:363–385.
   PubMed Web of Science ®Google Scholar
• Filling C, Berndt KD, Benach J, Knapp S, Prozorovski T, Nordling E, Ladenstein R, Jörnvall H, Oppermann U. 2002. Critical residues for structure and catalysis in short-chain dehydrogenases/reductases. J Biol Chem. 277:25677–25684.
   PubMed Web of Science ®Google Scholar
• Garattini E, Fratelli M, Terao M. 2009. The mammalian aldehyde oxidase gene family. Hum Genomics. 4:119–130.
   PubMedGoogle Scholar
• Garattini E, Terao M. 2012. The role of aldehyde oxidase in drug metabolism. Expert Opin Drug Metab Toxicol. 8:487–503.
   PubMed Web of Science ®Google Scholar
• Giebułtowicz J, Dziadek M, Wroczyński P, Woźnicka K, Wojno B, Pietrzak M, Wierzchowski J. 2010. Salivary aldehyde dehydrogenase - temporal and population variability, correlations with drinking and smoking habits and activity towards aldehydes contained in food. Acta Biochim Pol. 57:361–368.
   PubMed Web of Science ®Google Scholar
• Giebułtowicz J, Wolinowska R, Sztybor A, Pietrzak M, Wroczyński P, Wierzchowski J. 2009. Salivary aldehyde dehydrogenase: activity towards aromatic aldehydes and comparison with recombinant ALDH3A1. Molecules. 14:2363–2372.
   PubMed Web of Science ®Google Scholar
• Giebułtowicz J, Wroczyński P, Piekarczyk J, Wierzchowski J. 2008. Fluorimetric detection of aldehyde dehydrogenase activity in human tissues in diagnostic of cancers of oral cavity. Acta Pol Pharm. 65:81–84.
   PubMed Web of Science ®Google Scholar
• Giebułtowicz J, Wroczyński P, Samolczyk-Wanyura D. 2013. Can lower aldehyde dehydrogenase activity in saliva be a risk factor for oral cavity cancer? Oral Dis. 19:763–766.
   PubMed Web of Science ®Google Scholar
• Giebułtowicz J, Wroczyński P, Wierzchowski J. 2010. Salivary aldehyde dehydrogenase activity-influence of drugs intake, preliminary research. Acta Pol Pharm. 67:615–619.
   PubMed Web of Science ®Google Scholar
• Giorgianni F, Bridson PK, Sorrentino BP, Pohl J, Blakley RL. 2000. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. Biochem Pharmacol. 60(3):325–338.
   Google Scholar
• Glatt H, Rost K, Frank H, Seidel A, Kollock R. 2008. Detoxification of promutagenic aldehydes derived from methylpyrenes by human aldehyde dehydrogenases ALDH2 and ALDH3A1. Arch Biochem Biophys. 477:196–205.
   PubMed Web of Science ®Google Scholar
• Greenfield NJ, Pietruszko R. 1977. Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes. Biochim Biophys Acta.483:35–45.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Cheng Q. 2011. Orphans in the Human Cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Pharmacol Rev. 63:684–699.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Isin EM. 2008. Mechanisms of cytochrome P450 reactions. Acta Chim Slov. 55:7–19.
   Web of Science ®Google Scholar
• Harada S, Agarwal DP, Goedde HW. 1980. Electrophoretic and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues. Life Sci. 26:1773–1780.
   PubMed Web of Science ®Google Scholar
• Harvey WK, Lindahl R. 1982. Activity of various aldehyde-metabolizing enzymes in chemically-induced rat hepatomas. Biochem Pharmacol. 31:1153–1155.
   PubMed Web of Science ®Google Scholar
• Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. 1995. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure. 3:41–62.
   PubMed Web of Science ®Google Scholar
• Hasler JA, Estabrook R, Murray M, Pikuleva I, Waterman M, Capdevila J, Holla V, Helvig C, Falck JR, Farrell G, et al. 1999. Human cytochromes P450. Mol Aspects Med. 20:1–137.
   Google Scholar
• Hellgren M, Strömberg P, Gallego O, Martras S, Farrés J, Persson B, Parés X, Höög JO. 2007. Alcohol dehydrogenase 2 is a major hepatic enzyme for human retinol metabolism. Cell Mol Life Sci. 64(4):498–505.
   Google Scholar
• Hempel J, Liu ZJ, Perozich J, Rose J, Lindahl R, Wang BC. 1996. Conserved residues in the aldehyde dehydrogenase family. Adv Exp Med Biol. 414:9–13.
   Google Scholar
• Hempel J, Perozich J, Chapman T, Rose J, Boesch JS, Liu ZJ, Lindahl R, Wang BC. 1999. Aldehyde dehydrogenase catalytic mechanism. A proposal. Adv Exp Med Biol. 463:53–59.
   PubMed Web of Science ®Google Scholar
• Hilton J. 1984. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res. 44:5156–5160.
   PubMed Web of Science ®Google Scholar
• Holmes RS. 1994. Alcohol dehydrogenases: a family of isozymes with differential functions. Alcohol Alcohol Suppl. 2:127–130.
   PubMedGoogle Scholar
• Höög JO, Hedberg JJ, Strömberg P, Svensson S. 2001. Mammalian alcohol dehydrogenase - functional and structural implications. J Biomed Sci. 8:71–76.
   PubMed Web of Science ®Google Scholar
• Jackson B, Brocker C, Thompson DC, Black W, Vasiliou K, Nebert DW, Vasiliou V. 2011. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics. 5:283–303.
   PubMedGoogle Scholar
• Jang J-H, Bruse S, Liu Y, Duffy V, Zhang C, Oyamada N, Randell S, Matsumoto A, Thompson DC, Lin Y, et al. 2014. Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity. Free Radic Biol Med. 68:80–86.
   PubMed Web of Science ®Google Scholar
• Januchowski R, Wojtowicz K, Zabel M. 2013. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother. 67:669–680.
   PubMed Web of Science ®Google Scholar
• Jelski W, Szmitkowski M. 2008. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta. 395:1–5.
   PubMed Web of Science ®Google Scholar
• Jester JV, Moller-Pedersen T, Huang J, Sax CM, Kays WT, Cavangh HD, Petroll WM, Piatigorsky J. 1999. The cellular basis of corneal transparency: evidence for ‘corneal crystallins’. J Cell Sci. 112:613–622.
   PubMed Web of Science ®Google Scholar
• Jin Y, Penning TM. 2007. ‘Aldo-keto reductases and bioactivation/detoxication’. Annu Rev Pharmacol Toxicol. 47:263–292.
   PubMed Web of Science ®Google Scholar
• Johansson K, El-Ahmad M, Ramaswamy S, Hjelmqvist L, Jörnvall H, Eklund H. 1998. Structure of betaine aldehyde dehydrogenase at 2.1A0 resolution. Protein Sci. 7:2106–2117.
   PubMed Web of Science ®Google Scholar
• Jones KH, Lindahl R, Baker DC, Timkovich R. 1987. Hydride transfer stereospecificity of rat liver aldehyde dehydrogenases. J Biol Chem. 262:10911–10913.
   PubMed Web of Science ®Google Scholar
• Kallberg Y, Oppermann U, Jörnvall H, Persson B. 2002. Short-chain dehydrogenases/reductases (SDRs). Eur J Biochem. 269:4409–4417.
   PubMedGoogle Scholar
• Kang JH, Lee S-H, Hong D, Lee J-S, Ahn H-S, Ahn J-H, Seong TW, Lee C-H, Jang H, Hong KM, et al. 2016. Aldehyde dehydrogenase is used by cancer cells for energy metabolism. Exp Mol Med. 48:e272.
   PubMed Web of Science ®Google Scholar
• Kavanagh KL, Jörnvall H, Persson B, Oppermann U. 2008. Medium- and short-chain dehydrogenase/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci. 65:3895–3906.
   PubMed Web of Science ®Google Scholar
• Kedderis GL. 2010. Biotransformation of toxicants. Compr Toxicol. 1:137–150.
   Google Scholar
• Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, Swenberg JA. 1983. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43:4382–4392.
   PubMed Web of Science ®Google Scholar
• Kimble-Hill AC, Younus H, Meroueh S, Hurley TD. 2011. Structure based inhibition of mitochondrial aldehyde dehydrogenase (ALDH2) activity. Biophys J. 100:215a.
   PubMed Web of Science ®Google Scholar
• King G, Holmes R. 1997. Human corneal and lens aldehyde dehydrogenases. Purification and properties of human lens ALDH1 and differential expression as major soluble proteins in human lens (ALDH1) and cornea (ALDH3). Adv Exp Med Biol. 414:19–27.
   PubMedGoogle Scholar
• Kitson TM, Kitson KE. 1996. A comparison of nitrophenyl esters and lactones as substrates of cytosolic aldehyde dehydrogenase. Biochem J. 316:225–232.
   PubMed Web of Science ®Google Scholar
• Könst P, Merkens H, Kara S, Kochius S, Vogel A, Zuhse R, Holtmann D, Arends IW, Hollmann F. 2012. Enantioselective oxidation of aldehydes catalyzed by alcohol dehydrogenase. Angew Chem Int Ed Engl. 51:9914–9917.
   PubMed Web of Science ®Google Scholar
• Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V. 2012. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev. 64:520–539.
   PubMed Web of Science ®Google Scholar
• Koren H, Bisesi M. 2003. Handbook of environmental health. 4th ed. Boca Raton (FL): Lewis Publishers/CRC Press.
   Google Scholar
• Korkalainen MK, Törrönen AR, Kärenlampi SO. 1995. Comparison of expression of aldehyde dehydrogenase 3 and CYP1A1 in dominant and recessive aryl hydrocarbon hydroxylase-deficient mutant mouse hepatoma cells. Chem Biol Interact. 94:121–134.
   PubMed Web of Science ®Google Scholar
• Kratzer R, Wilson DK, Nidetzky B. 2006. Catalytic mechanism and substrate selectivity of aldo-keto reductases: insights from structure-function studies of Candida tenuis xylose reductase. IUBMB Life. 58:499–507.
   PubMed Web of Science ®Google Scholar
• Lachenmeier DW, Salaspuro M. 2017. ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde. Regul Toxicol Pharmacol. 86:128–136.
   PubMed Web of Science ®Google Scholar
• Landin JS, Cohen SD, Khairallah EA. 1996. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol Appl Pharmacol. 141:299–307.
   PubMed Web of Science ®Google Scholar
• Laskar AA, Alam MF, Ahmad M, Younus H. 2018. Kinetic and biophysical investigation of the inhibitory effect of caffeine on human salivary aldehyde dehydrogenase: Implications in oral health and chemotherapy. J Mol Struct. 1157:61–68.
   Web of Science ®Google Scholar
• Laskar AA, Alam MF, Younus H. 2017. In vitro activity and stability of pure human salivary aldehyde dehydrogenase. Int J Biol Macromol. 96:798–806.
   PubMed Web of Science ®Google Scholar
• Laskar AA, Khan MA, Askari F, Younus H. 2017. Thymoquinone binds and activates human salivary aldehyde dehydrogenase: Potential therapy for the mitigation of aldehyde toxicity and maintenance of oral health. Int J Biol Macromol. 103:99–110.
   PubMed Web of Science ®Google Scholar
• Lassen N, Pappa A, Black WJ, Jester JV, Day BJ, Min E, Vasiliou V. 2006. Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts. Free Radic Biol Med. 41:1459–1469.
   PubMed Web of Science ®Google Scholar
• Lee C, Bedgar DL, Davin LB, Lewis NG. 2013. Assessment of a putative proton relay in Arabidopsis cinnamyl alcohol dehydrogenase catalysis. Org Biomol Chem. 11:1127–1134.
   PubMed Web of Science ®Google Scholar
• Li J, Bluth MH. 2011. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy. Pharmgenomics Pers Med. 4:11–33.
   PubMedGoogle Scholar
• Lin SW, Chen JC, Hsu LC, Hsieh CL, Yoshida A. 1996. Human gamma-aminobutyraldehyde dehydrogenase (ALDH9): cDNA sequence, genomic organization, polymorphism, chromosomal localization, and tissue expression. Genomics. 34:376–380.
   PubMed Web of Science ®Google Scholar
• Lindahl R. 1992. Aldehyde dehydrogenases and their role in carcinogenesis. Crit Rev Biochem Mol Biol. 27:283–335.
   PubMed Web of Science ®Google Scholar
• Lindahl R, Hempel J. 1991. Aldehyde dehydrogenases: what can be learned from a baker's dozen sequences? Adv Exp Med Biol. 1:1–8.
   Google Scholar
• Liu X, Wang Y, Han K. 2007. Systematic study on the mechanism of aldehyde oxidation to carboxylic acid by cytochrome P450. J Biol Inorg Chem. 12:1073–1081.
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Hempel J, Sun J, Rose J, Hsiao D, Chang WR, Chung YJ, Kuo I, Lindahl R, Wang BC. 1996. Crystal structure of a class 3 aldehyde dehydrogenase at 2.6Å resolution. Adv Exp Med Biol. 414:1–7.
   Google Scholar
• Liu ZJ, Sun YJ, Rose J, Chung YJ, Hsiao CD, Chang WR, Kuo I, Perozich J, Lindahl R, Hempel J, Wang BC. 1997. The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat Struct Biol. 4:317–326.
   PubMedGoogle Scholar
• LoPachin RM, Gavin T. 2014. Molecular mechanisms of aldehyde toxicity: a chemical perspective. Chem Res Toxicol. 27:1081–1091.
   PubMed Web of Science ®Google Scholar
• Ma I, Allan AL. 2011. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7:292–306.
   PubMed Web of Science ®Google Scholar
• Magni M, Shammah S, Schiró R, Mellado W, Dalla-Favera R, Gianni AM. 1996. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 87:1097–1103.
   PubMed Web of Science ®Google Scholar
• Malátková P, Maser E, Wsól V. 2010. Human carbonyl reductases. Curr Drug Metab. 11:639–658.
   PubMed Web of Science ®Google Scholar
• Manikandan P, Nagini S. 2018. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 19:38–54.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Brocker C, Stagos D, Vasiliou V. 2008. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 4:697–720.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Chen Y, Thompson DC, Vasiliou V. 2011. Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. Eye Contact Lens. 37:206–213.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Deitrich RA, Vasiliou V. 2007. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev. 59:125–150.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. 1988. Health effects of aldehydes and alcohols in mobile source emissions. In: Watson AY, Bates RR, Kennedy D, editors. Air pollution, the automobile, and public health. Washington (DC): National Academies Press; p. 579–603.
   Google Scholar
• McMahon RE. 1982. Alcohols, aldehydes, and ketones. In: Jakoby WB, Bend JR, Caldwell J, editors. Metabolic basis of detoxication. New York: Academic Press; p. 91–104.
   Google Scholar
• Mindnich RD, Penning TM. 2009. Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum Genomics. 3:362–370.
   PubMedGoogle Scholar
• Miyauchi K, Masaki R, Taketani S, Yamamoto A, Akayama M, Tashiro Y. 1991. Molecular cloning, sequencing, and expression of cDNA for rat liver microsomal aldehyde dehydrogenase. J Biol Chem. 266:19536–19542.
   PubMed Web of Science ®Google Scholar
• Montefiori M, Jørgensen FS, Olsen L. 2017. Aldehyde oxidase: reaction mechanism and prediction of site of metabolism. ACS Omega. 2:4237–4244.
   PubMed Web of Science ®Google Scholar
• Moreb J, Schweder M, Suresh A, Zucali JR. 1996. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxy cyclophosphamide. Cancer Gene Ther. 3:24–30.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Gabr A, Vartikar GR, Gowda S, Zucali JR, Mohuczy D. 2005. Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde. J Pharmacol Exp Ther. 312:339–345.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Mohuczy D, Muhoczy D, Ostmark B, Zucali JR. 2007. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother Pharmacol. 59:127–136.
   PubMed Web of Science ®Google Scholar
• Moriyasu A, Sugihara K, Nakatani K, Ohta S, Kitamura S. 2006. In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats . Drug Metab Pharmacokinet. 21:485–491.
   PubMed Web of Science ®Google Scholar
• Mukerjee N, Pietruszko R. 1992. Human mitochondrial aldehyde dehydrogenase substrate specificity: comparison of esterase with dehydrogenase reaction. Arch Biochem Biophys. 299:23–29.
   PubMed Web of Science ®Google Scholar
• Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA. 2012. Aldehyde dehydrogenases and cell proliferation. Free Radic Biol Med. 52:735–746.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Wikvall K, Miller WL. 2013. Human cytochromes P450 in health and disease. Philos Trans R Soc London Ser B. 368:20120431.
   PubMed Web of Science ®Google Scholar
• Nelson MM, Baba SP, Anderson EJ. 2017. Biogenic aldehydes as therapeutic targets for cardiovascular disease. Curr Opin Pharmacol. 33:56–63.
   PubMed Web of Science ®Google Scholar
• Niederreither K, Fraulob V, Garnier JM, Chambon P, Dollé P. 2002. Differential expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation in the mouse. Mech Dev. 110:165–171.
   PubMed Web of Science ®Google Scholar
• O’Brien PJ, Diraki AG, Shangari N. 2005. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol. 35:609–662.
   PubMed Web of Science ®Google Scholar
• Oppermann UC, Filling C, Jörnvall H. 2001. Forms and functions of human SDR enzymes. Chem Biol Interact. 130–132:699–705.
   PubMed Web of Science ®Google Scholar
• Oppermann UC, Maser E. 2000. Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology. 144:71–81.
   PubMed Web of Science ®Google Scholar
• Pappa A, Chen C, Koutalos Y, Townsend AJ, Vasiliou V. 2003. ALDH3A1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic Biol Med. 34:1178–1189.
   PubMed Web of Science ®Google Scholar
• Pappa A, Estey T, Manzer R, Brown D, Vasiliou V. 2003. Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. Biochem J. 376:615–623.
   PubMed Web of Science ®Google Scholar
• Parajuli B, Georgiadis TM, Fishel ML, Hurley TD. 2014. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity. Chembiochem. 15:701–712.
   PubMed Web of Science ®Google Scholar
• Parajuli B, Kimble-Hill AC, Khanna M, Ivanova Y, Meroueh S, Hurley TD. 2011. Discovery of novel regulators of aldehyde dehydrogenase isoenzymes. Chem Biol Interact. 191:153–158.
   PubMed Web of Science ®Google Scholar
• Parlesak A, Billinger MH, Bode C, Bode JC. 2002. Gastric alcohol dehydrogenase activity in man: influence of gender, age, alcohol consumption and smoking in a caucasian population. Alcohol Alcohol. 37(4):388–393.
   Google Scholar
• Patel M, Lu L, Zander DS, Sreerama L, Coco D, Moreb JS. 2008. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer. 59:340–349.
   PubMed Web of Science ®Google Scholar
• Penner N, Woodward C, Prakash C. 2012. Drug metabolizing enzymes and biotransformation reactions. In: Zhang D, Surapaneni S, editors. ADME-enabling technologies in drug design and development. Hoboken, NJ (USA): John Wiley & Sons, Inc.; p. 545–565.
   Google Scholar
• Penning TM. 2015. The aldo-keto reductases (AKRs): overview. Chem Biol Interact. 234:236–246.
   PubMed Web of Science ®Google Scholar
• Penning TM, Drury JE. 2007. Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch Biochem Biophys. 464:241–250.
   PubMed Web of Science ®Google Scholar
• Pereira F, Rosenmann E, Nylen E, Kaufman M, Pinsky L, Wrogemann K. 1991. The 56 kDa androgen binding protein is an aldehyde dehydrogenase. Biochem Biophys Res Commun. 175:831–838.
   PubMed Web of Science ®Google Scholar
• Perez-Miller S, Younus H, Vanam R, Chen CH, Mochly-Rosen D, Hurley TD. 2010. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol. 17:159–164.
   PubMed Web of Science ®Google Scholar
• Perez-Miller SJ, Hurley TD. 2003. Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry. 42:7100–7109.
   PubMed Web of Science ®Google Scholar
• Perozich J, Nicholas H, Lindahl R, Hempel J. 1999. The big book of aldehyde dehydrogenase sequences. An overview of the extended family. Adv Exp Med Biol. 463:1–7.
   PubMed Web of Science ®Google Scholar
• Persson B, Kallberg Y, Bray JE, Bruford E, Dellaporta SL, Favia AD, Duarte RG, Jörnvall H, Kavanagh KL, Kedishvili N, et al. 2009. The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. Chem Biol Interact. 178:94–98.
   PubMed Web of Science ®Google Scholar
• Persson B, Krook M, Jörnvall H. 1991. Characteristics of short-chain alcohol dehydrogenases and related enzymes. Eur J Biochem. 200:537–543.
   PubMedGoogle Scholar
• Pors K, Moreb JS. 2014. Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development? Drug Discov Today. 19:1953–1963.
   PubMed Web of Science ®Google Scholar
• Rekha GK, Sladek NE. 1997. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Adv Exp Med Biol. 414:133–146.
   PubMedGoogle Scholar
• Rendic S, Di Carlo FJ. 1997. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 29:413–580.
   PubMed Web of Science ®Google Scholar
• Sanoh S, Tayama Y, Sugihara K, Kitamura S, Ohta S. 2015. Significance of aldehyde oxidase during drug development: effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metab Pharmacokinet. 30:52–63.
   PubMed Web of Science ®Google Scholar
• Schnier JB, Kaur G, Kaiser A, Stinson SF, Sausville EA, Gardner J, Nishi K, Bradbury EM, Senderowicz AM. 1999. Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein. FEBS Lett. 454:100–104.
   PubMed Web of Science ®Google Scholar
• Sidhu RS, Blair AH. 1975. Human liver aldehyde dehydrogenase. Esterase activity. J Biol Chem. 250:7894–7898.
   PubMed Web of Science ®Google Scholar
• Sladek NE. 1999. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr Pharm Des. 5:607–625.
   PubMed Web of Science ®Google Scholar
• Sladek NE. 2002. Leukemic cell insensitivity to cyclophosphamide and other oxazaphosphorines mediated by aldehyde dehydrogenase(s). Cancer Treat Res. 112:161–175.
   PubMedGoogle Scholar
• Sladek NE. 2003. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol. 17:7–23.
   PubMed Web of Science ®Google Scholar
• Sladek NE, Sreerama L, Rekha GK. 1995. Constitutive and overexpressed human cytosolic class-3 aldehyde dehydrogenases in normal and neoplastic cells/secretions. Adv Exp Med Biol. 372:103–114.
   PubMedGoogle Scholar
• Sodhi JK, Wong S, Kirkpatrick DS, Liu L, Khojasteh SC, Hop CE, Barr JT, Jones JP, Halladay JS. 2015. A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834. Drug Metab Dispos. 43:908–915.
   PubMed Web of Science ®Google Scholar
• Sreerama L, Hedge MW, Sladek NE. 1995. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin Cancer Res. 1:1153–1165.
   PubMed Web of Science ®Google Scholar
• Sreerama L, Sladek NE. 1993. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine specific acquired resistance. Biochem Pharmacol. 45:2487–2505.
   PubMed Web of Science ®Google Scholar
• Sreerama L, Sladek NE. 1997. Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. Clin Cancer Res. 3:1901–1914.
   PubMed Web of Science ®Google Scholar
• Stachowicz A, Olszanecki R, Suski M, Wiśniewska A, Totoń-Żurańska J, Madej J, Jawień J, Białas M, Okoń K, Gajda M, et al. 2014. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. J Am Heart Assoc. 3:e001329.
   PubMed Web of Science ®Google Scholar
• Svensson S, Lundsjö A, Cronholm T, Höög JO. 1996. Aldehyde dismutase activity of human liver alcohol dehydrogenase. FEBS Lett. 394:217–220.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Weiner H. 1980. Magnesium stimulation of catalytic activity of horse liver aldehyde dehydrogenase. Changes in molecular weight and catalytic sites. J Biol Chem. 255:8206–8209.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Weiner H. 1981. Nicotinamide adenine dinucleotide activation of the esterase reaction of horse liver aldehyde dehydrogenase. Biochemistry. 20:2720–2726.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Weiner H, Filmer DL. 1981. Effects of pH on horse liver aldehyde dehydrogenase: alterations in metal ion activation, number of functioning active sites, and hydrolysis of the acyl intermediate. Biochemistry. 20:6225–6230.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Weiner H, Hu JHJ. 1980. Increase in the stoichiometry of the functioning active sites of horse liver aldehyde dehydrogenase in the presence of magnesium ions. Arch Biochem Biophys. 205:571–578.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Nonaka T, Nakamura KT, Hara A. 2001. SDR structure, mechanism of action, and substrate recognition. Curr Org Chem. 5:89–111.
   Web of Science ®Google Scholar
• Terao M, Kurosaki M, Demontis S, Zanotta S, Garattini E. 1998. Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin. Biochem J. 332:383–393.
   PubMed Web of Science ®Google Scholar
• Terao M, Romão M J, Leimkühler S, Bolis M, Fratelli M, Coelho C, Santos-Silva T, Garattini E. 2016. Structure and function of mammalian aldehyde oxidases. Arch Toxicol. 90:753–780.
   PubMed Web of Science ®Google Scholar
• Townsend AJ, Leone-Kabler S, Haynes RL, Wu Y, Szweda L, Bunting KD. 2001. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem Biol Interact. 130–132:261–273.
   PubMed Web of Science ®Google Scholar
• Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, Gray BA, Moreb JS. 2009. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact. 178:48–55.
   PubMed Web of Science ®Google Scholar
• van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzmán-Ramírez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini MG, et al. 2010. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res. 70:5163–5173.
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Bairoch A, Tipton KF, Nebert DW. 1999. Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Pharmacogenetics. 9:421–434.
   PubMedGoogle Scholar
• Vasiliou V, Nebert DW. 2005. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics. 2:138–143.
   PubMedGoogle Scholar
• Vasiliou V, Pappa A. 2000. Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology. 61:192–198.
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Pappa A, Estey T. 2004. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev. 36:279–299.
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Pappa A, Petersen DR. 2000. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem Biol Interact. 129:1–19.
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y. 2013. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact. 202:2–10.
   PubMed Web of Science ®Google Scholar
• Voulgaridou GP, Anestopoulos I, Franco R, Panayiotidis MI, Pappa A. 2011. DNA damage induced by endogenous aldehydes: current state of knowledge. Mutat Res. 711:13–27.
   PubMed Web of Science ®Google Scholar
• Walsh C, editor. 1979. Enzymatic reaction mechanisms. San Francisco: WH Freeman Co.
   Google Scholar
• Wang GW, Guo Y, Vondriska TM, Zhang J, Zhang S, Tsai LL, Zong NC, Bolli R, Bhatnagar A, Prabhu SD. 2008. Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. J Mol Cell Cardiol. 44:1016–1022.
   PubMed Web of Science ®Google Scholar
• Wierzchowski J, Pietrzak M, Szelag M, Wroczyński P. 2008. Salivary aldehyde dehydrogenase-reversible oxidation of the enzyme and its inhibition by caffeine, investigated using fluorimetric method. Arch Oral Biol. 53:423–428.
   PubMed Web of Science ®Google Scholar
• Xiao N, Cao H, Chen C.-H, Kong C. S, Ali R, Chan C, Sirjani D, Graves E, Koong A, Giaccia A, et al. 2013. A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Clin Cancer Res. 19:4455–4464.
   PubMed Web of Science ®Google Scholar
• Yin SJ, Wang SL, Liao CS, Jörnvall H. 1993. Human high-Km aldehyde dehydrogenase (ALDH3): molecular, kinetic and structural features. Adv Exp Med Biol. 328:87–98.
   PubMedGoogle Scholar
• Yoshida A, Hsu LC, Dave V. 1992. Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme. 46:239–244.
   PubMedGoogle Scholar
• Yoshida A, Rzhetsky A, Hsu LC, Chang C. 1998. Human aldehyde dehydrogenase gene family. Eur J Biochem. 251:549–557.
   PubMedGoogle Scholar
• Yoval-Sánchez B, Pardo JP, Rodríguez-Zavala JS. 2013. New insights into the half-of-the-sites reactivity of human aldehyde dehydrogenase 1A1. Proteins. 81:1330–1339.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ. 2005. Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metab Rev. 37:611–703.
   PubMed Web of Science ®Google Scholar
• Zhong W, Zhang W, Li Q, Xie G, Sun Q, Sun X, Tan X, Sun X, Jia W, Zhou Z. 2015. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice. J Hepatol.62:1375–1381.
   PubMed Web of Science ®Google Scholar
• Zhou J, Weiner H. 1997. Binding of thyroxine analogs to human liver aldehyde dehydrogenases. Eur J Biochem. 245:123–128.
   PubMedGoogle Scholar